Three-dimensional alteration of neurites in schizophrenia.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
12 02 2019
Historique:
received: 03 09 2018
accepted: 24 01 2019
revised: 06 12 2018
entrez: 14 2 2019
pubmed: 14 2 2019
medline: 16 1 2020
Statut: epublish

Résumé

Psychiatric symptoms of schizophrenia suggest alteration of cerebral neurons. However, the physical basis of the schizophrenia symptoms has not been delineated at the cellular level. Here, we report nanometer-scale three-dimensional analysis of brain tissues of schizophrenia and control cases. Structures of cerebral tissues of the anterior cingulate cortex were visualized with synchrotron radiation nanotomography. Tissue constituents visualized in the three-dimensional images were traced to build Cartesian coordinate models of tissue constituents, such as neurons and blood vessels. The obtained Cartesian coordinates were used for calculating curvature and torsion of neurites in order to analyze their geometry. Results of the geometric analyses indicated that the curvature of neurites is significantly different between schizophrenia and control cases. The mean curvature of distal neurites of the schizophrenia cases was ~1.5 times higher than that of the controls. The schizophrenia case with the highest neurite curvature carried a frame shift mutation in the GLO1 gene, suggesting that oxidative stress due to the GLO1 mutation caused the structural alteration of the neurites. The differences in the neurite curvature result in differences in the spatial trajectory and hence alter neuronal circuits. It has been shown that the anterior cingulate cortex analyzed in this study has emotional and cognitive functions. We suggest that the structural alteration of neurons in the schizophrenia cases should reflect psychiatric symptoms of schizophrenia.

Identifiants

pubmed: 30755587
doi: 10.1038/s41398-019-0427-4
pii: 10.1038/s41398-019-0427-4
pmc: PMC6372695
doi:

Substances chimiques

GLO1 protein, human EC 4.4.1.5
Lactoylglutathione Lyase EC 4.4.1.5

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

85

Références

Biol Psychiatry. 1999 Jun 15;45(12):1542-52
pubmed: 10376114
J Comput Assist Tomogr. 1997 Jul-Aug;21(4):539-53
pubmed: 9216758
Micron. 2010 Jan;41(1):90-5
pubmed: 19800246
Biol Psychiatry. 1999 Jan 1;45(1):17-25
pubmed: 9894571
J Neurosci. 2009 Oct 14;29(41):12768-75
pubmed: 19828788
Schizophr Bull. 2009 Sep;35(5):973-93
pubmed: 18436528
Schizophr Bull. 2012 Sep;38(5):920-6
pubmed: 22987850
Arch Gen Psychiatry. 2010 Jun;67(6):589-97
pubmed: 20530008
J Synchrotron Radiat. 2007 May;14(Pt 3):282-7
pubmed: 17435304
Neurosci Lett. 2015 Aug 5;601:46-53
pubmed: 25478958
Cereb Cortex. 2001 Jun;11(6):558-71
pubmed: 11375917
Adv Mater. 2017 Nov;29(41):
pubmed: 28906570
Acta Neuropathol. 2001 Oct;102(4):373-9
pubmed: 11603813
Nature. 2017 May 18;545(7654):345-349
pubmed: 28489821
Biol Psychiatry. 2011 Jul 1;70(1):88-96
pubmed: 21457946
Neurobiol Dis. 1998 Nov;5(5):305-22
pubmed: 10069574
Cereb Cortex. 2010 Jul;20(7):1739-48
pubmed: 19915092
Mol Brain. 2017 Dec 12;10(1):60
pubmed: 29233179
Am J Psychiatry. 2005 Jun;162(6):1200-2
pubmed: 15930070
Am J Hum Genet. 2001 Aug;69(2):428-33
pubmed: 11443544
N Engl J Med. 1994 Mar 10;330(10):681-90
pubmed: 8107719
Arch Gen Psychiatry. 2000 Jan;57(1):65-73
pubmed: 10632234
Nat Rev Neurosci. 2001 Dec;2(12):880-8
pubmed: 11733795
Nature. 2011 Mar 10;471(7337):183-8
pubmed: 21390125
Micron. 2014 Jun;61:9-19
pubmed: 24792442
Schizophr Bull. 2013 Sep;39(5):1129-38
pubmed: 23042112
Front Neurosci. 2007 Oct 15;1(1):131-43
pubmed: 18982124
Brain Res. 2008 Mar 14;1199:53-61
pubmed: 18289513
Am J Psychiatry. 2000 Jan;157(1):16-25
pubmed: 10618008
J Microsc. 2015 Jan;261(1):57-66
pubmed: 26444300
Bioinformatics. 2017 May 1;33(9):1379-1386
pubmed: 28453669
Nat Methods. 2013 Jun;10(6):501-7
pubmed: 23722209
Proc Natl Acad Sci U S A. 2008 May 13;105(19):7076-81
pubmed: 18458327
Trends Cogn Sci. 2000 Jun;4(6):215-222
pubmed: 10827444
Neuroscience. 2013 Oct 22;251:90-107
pubmed: 22546337
Front Oncol. 2014 Dec 18;4:366
pubmed: 25566504
PLoS Med. 2016 Feb 16;13(2):e1001961
pubmed: 26881778
Nat Commun. 2018 Jun 14;9(1):2340
pubmed: 29904154
J Microsc. 2011 Nov;244(2):113-21
pubmed: 22004276
IEEE Trans Image Process. 1998;7(3):359-69
pubmed: 18276256
Nat Neurosci. 2015 Nov;18(11):1664-71
pubmed: 26457551
Nature. 1999 Nov 11;402(6758):179-81
pubmed: 10647008
IEEE Trans Inf Technol Biomed. 2002 Jun;6(2):171-87
pubmed: 12075671
Nat Rev Neurosci. 2006 Apr;7(4):318-24
pubmed: 16552417
J Struct Biol. 2013 Nov;184(2):271-9
pubmed: 24012710
Neuropsychopharmacology. 2009 Jan;34(2):374-89
pubmed: 18463626
J Am Acad Child Adolesc Psychiatry. 2004 Sep;43(9):1146-53
pubmed: 15322418
Neuroscience. 2006 Sep 1;141(3):1107-12
pubmed: 16797136
J Anat. 2010 Oct;217(4):324-33
pubmed: 20408906
Neuroscience. 2015 Sep 10;303:82-102
pubmed: 26116523
Psychiatry Clin Neurosci. 2014 Sep;68(9):655-65
pubmed: 24995521

Auteurs

Ryuta Mizutani (R)

Department of Applied Biochemistry, Tokai University, Hiratsuka, Kanagawa, 259-1292, Japan. mizutanilaboratory@gmail.com.

Rino Saiga (R)

Department of Applied Biochemistry, Tokai University, Hiratsuka, Kanagawa, 259-1292, Japan.

Akihisa Takeuchi (A)

Japan Synchrotron Radiation Research Institute (JASRI/SPring-8), Sayo, Hyogo, 679-5198, Japan.

Kentaro Uesugi (K)

Japan Synchrotron Radiation Research Institute (JASRI/SPring-8), Sayo, Hyogo, 679-5198, Japan.

Yasuko Terada (Y)

Japan Synchrotron Radiation Research Institute (JASRI/SPring-8), Sayo, Hyogo, 679-5198, Japan.

Yoshio Suzuki (Y)

Graduate School of Frontier Sciences, University of Tokyo, Kashiwa, Chiba, 277-8561, Japan.

Vincent De Andrade (V)

Advanced Photon Source, Argonne National Laboratory, Lemont, IL, 60439, USA.

Francesco De Carlo (F)

Advanced Photon Source, Argonne National Laboratory, Lemont, IL, 60439, USA.

Susumu Takekoshi (S)

Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan.

Chie Inomoto (C)

Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan.

Naoya Nakamura (N)

Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan.

Itaru Kushima (I)

Graduate School of Medicine, Nagoya University, Nagoya, Aichi, 466-8550, Japan.

Shuji Iritani (S)

Graduate School of Medicine, Nagoya University, Nagoya, Aichi, 466-8550, Japan.

Norio Ozaki (N)

Graduate School of Medicine, Nagoya University, Nagoya, Aichi, 466-8550, Japan.

Soichiro Ide (S)

Tokyo Metropolitan Institute of Medical Science, Setagaya, Tokyo, 156-8506, Japan.

Kazutaka Ikeda (K)

Tokyo Metropolitan Institute of Medical Science, Setagaya, Tokyo, 156-8506, Japan.

Kenichi Oshima (K)

Tokyo Metropolitan Institute of Medical Science, Setagaya, Tokyo, 156-8506, Japan.

Masanari Itokawa (M)

Tokyo Metropolitan Institute of Medical Science, Setagaya, Tokyo, 156-8506, Japan.

Makoto Arai (M)

Tokyo Metropolitan Institute of Medical Science, Setagaya, Tokyo, 156-8506, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH